Biotech Published on November 7, 2019 ExCellThera Inc., an advanced biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced the publication of full data from the first clinical trial using ECT-001 (single UM171-expanded cord blood) in patients with haematological malignancies. The data were published in the peer-reviewed medical journal, The Lancet Haematology. Read more
Business environment Published on November 5, 2019 Montréal among the best North American cities for job growth (french content) Read more
Pharma Published on November 5, 2019 Pharmascience launched pms-FINGOLIMOD. A generic drug with demonstrated bioequivalence to the brand product GILENYA® for the treatment of relapsing multiple sclerosis (MS) in adults. Read more
Biotech Published on November 5, 2019 Liminal BioSciences Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, announced the signature of a binding share purchase agreement for the divestment of its Isle of Man-based bioseparations business operated through its subsidiary Prometic Bioseparations Ltd to KKR, a leading global investment firm. Read more
Business environment Published on November 5, 2019 TandemLaunch, a start-up foundry and seed fund focused on creating, incubating and accelerating early-stage technology start-ups, announced the final close of the TandemLaunch Ventures III fund for total proceeds of approximately $30 million. This fund is dedicated to the creation of over twenty disruptive Quebec-based technology companies that have the potential for global commercialization. Read more
Artificial Intelligence Published on October 30, 2019 Minister Delegate for Digital Transformation Government, Eric Caire, will represent the Government of Quebec in Paris, October 29 and 30, 2019, at the Global Forum on AI for Humanity (GFAIH). (french content) Read more
Biotech Published on October 30, 2019 Feldan Therapeutics, based in Quebec City, wrote an article in collaboration with the Iowa University: “Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia” and was published in Nature Communications Read more
Biotech Published on October 30, 2019 Antech Diagnostics announced its acquisition of Quebec-based Biovet, a biotechnology company providing unique expertise in the field of diagnostics for animal health and agro-industry specialists in Canada and internationally. Read more
Biotech Published on October 30, 2019 Liminal BioSciences, headquartered in Laval, announces upcoming presentations new data on pulmonary arterial hypertension at the 2019 AHA meeting Read more